Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30

被引:29
作者
Thybo, Pia [2 ]
Pedersen, Betty L. [1 ]
Hovgaard, Lars [1 ]
Holm, Rene [3 ]
Mullertz, Anette [4 ]
机构
[1] Novo Nordisk AS, Diabet Res Unit, DK-2760 Malov, Denmark
[2] Nycomed, Pharmaceut Dev, Roskilde, Denmark
[3] H Lundbeck & Co AS, Preformulat, Valby, Denmark
[4] Univ Copenhagen, Fac Pharmaceut Sci, Dept Pharmaceut & Analyt Chem, DK-1168 Copenhagen, Denmark
关键词
amorphous; flow-through dissolution; solid dispersion; stability; spray drying; probucol;
D O I
10.1080/10837450802244843
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Main purpose of this Study was to obtain stable, well-characterized solid dispersions (SDs) of amorphous probucol and polyvinylpyrrolidone K-30 (PVP-K30) with improved dissolution rates. A secondary aim was to investigate the flow-through dissolution method for in-vitro dissolution measurements of small-sized amorphous powders dispersed in a hydrophilic polymer. SDs were prepared by spray drying Solutions of probucol and different amounts of PVP-K30. The obtained SDs were characterized by dissolution rate measurements in a flow-through apparatus, X-ray Powder Diffraction (XRPD), Differential Scanning Calorimetry (DSC), Scanning Electron Microscopy (SEM), particle sizing (laser diffraction) and Brunauer-Emmett-Teller Method (BET) and results were compared with starting material and a physical mixture. The physical stability was monitored after storage at 25 degrees C and 60% RH for up to 12 weeks. The flow-through method was found suitable as dissolution method. All SDs showed improved in-vitro dissolution rates when compared to starting material and physical mixtures. The greatest improvement in the in-vitro dissolution rate was observed for the highest polymer to drug ratio. By means of the results from XRPD and DSC, it was argued that the presence of amorphous probucol improved the dissolution rate, but the amorphous state Could not fully account for the difference in dissolution profiles between the SDs. It was suggested that the increase in surface area due to the reduction in particle size contributed to an increased dissolution rate as well as the presence of PVP-K30 by preventing aggregation and drug re-crystallization and by improving wettability during dissolution. The stabilizing effect of the polymer was verified in the solid state, as all the SDs retained probucol in the amorphous state throughout the entire length of the stability study.
引用
收藏
页码:375 / 386
页数:12
相关论文
共 28 条
[1]   Stability study of amorphous valdecoxib [J].
Ambike, AA ;
Mahadik, KR ;
Paradkar, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 282 (1-2) :151-162
[2]   Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus [J].
Bhattachar, SN ;
Wesley, JA ;
Fioritto, A ;
Martin, PJ ;
Babu, SR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 236 (1-2) :135-143
[3]   A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug [J].
Broman, E ;
Khoo, C ;
Taylor, LS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 222 (01) :139-151
[4]  
Brown CK, 2004, Pharm Tech, V28, P56, DOI [10.14227/DT120405P6, DOI 10.14227/DT120405P6]
[5]  
CDER, 1997, GUID IND DISS TEST I, P1
[6]   Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution - Pros and cons [J].
Chokshi, Rina J. ;
Zia, Hossein ;
Sandhu, Harpreet K. ;
Shah, Navnit H. ;
Malick, Waseem A. .
DRUG DELIVERY, 2007, 14 (01) :33-45
[7]   The mechanisms of drug release from solid dispersions in water-soluble polymers [J].
Craig, DQM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (02) :131-144
[8]   The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems [J].
Craig, DQM ;
Royall, PG ;
Kett, VL ;
Hopton, ML .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 179 (02) :179-207
[9]   Dissolution media for in vitro testing of water-insoluble drugs: Effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate [J].
Crison, JR ;
Weiner, ND ;
Amidon, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :384-388
[10]   Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers [J].
Emara, LH ;
Badr, RM ;
Abd Elbary, A .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (07) :795-807